To date, the only therapeutic treatment for Laron syndrome is recombinant IGF-I, which has been shown to have various side effects, including hypoglycemia, thymic hypertrophy, snoring and hypoacusis [5]. This evidence concerns the gene IGF1 and Laron syndrome.